The role of endothelial progenitor cells in tumour vasculogenesis

Pathobiology

Volumn 75, Issue 5, 2008, Pages 265-273

  Ding, Yi Tao ^a   Kumar, Shant ^b   Yu, De Cai ^a  

^a NANJING UNIVERSITY   (China)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Angiogenesis; Endothelial progenitor cells; Targeting therapy; Tumour vasculature; Vasculogenesis

Indexed keywords

ANGIOPOIETIN RECEPTOR; GANCICLOVIR; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; PROTAMINE SULFATE; SUPERPARAMAGNETIC IRON OXIDE; THYMIDINE KINASE; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER THERAPY; CANCER TISSUE; CD34 SELECTION; CELL DIFFERENTIATION; CELL HOMING; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELLULAR DISTRIBUTION; ENDOTHELIUM CELL; HUMAN; IN VIVO STUDY; MEDLINE; MICROENVIRONMENT; NONHUMAN; PERICYTE; PRIORITY JOURNAL; REVIEW; STEM CELL; STROMA CELL; SYSTEMATIC REVIEW; TUMOR CELL; TUMOR VASCULARIZATION;

ANIMALS; ENDOTHELIUM, VASCULAR; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; STEM CELLS;

EID: 54249104115     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151706     Document Type: Review

References (61)

1. Asahara T, Masuda H, Takahashi T, et al: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221-228.
2. Lyden D, Hattori K, Dias S, et al: Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumour angiogenesis and growth. Nat Med 2001;7:1194-1201.
3. Yu DC, Sun XT, Qiu YD, et al: Identification and clinical significance of mobilized endothelial progenitor cells in tumour vasculogenesis of hepatocellular carcinoma. Clin Cancer Res 2007;13:3814-3824.
4. De Palma M, Venneri MA, Roca C, Naldini L: Targeting exogenous genes to tumour angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med 2003;9:789-795.
5. Beaudry P, Force J, Naumov GN, et al: Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells: implications for use as a surrogate marker of antiangiogenic activity. Clin Cancer Res 2005;11:3514-3522.
6. Garmy-Susini B, Varner JA: Circulating endothelial progenitor cells. Br J Cancer 2005;93:855-858.
7. Ozerdem U, Alitalo K, Salven P, Li A: Contribution of bone marrow-derived pericyte precursor cells to corneal vasculogenesis. Invest Ophthalmol Vis Sci 2005;46:3502-3506.
8. Stump MM, Jordan GL Jr, Debakey ME, Halpert B: Endothelium grown from circulating blood on isolated intravascular Dacron hub. Am J Pathol 1963;43:361-367.
9. Asahara T, Murohara T, Sullivan A, et al: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967.
10. Asahara T, Takahashi T, Masuda H, et al: VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999;18:3964-3972.
11. Kang HJ, Kim SC, Kim YJ, et al: Short-term phytohaemagglutinin-activated mononuclear cells induce endothelial progenitor cells from cord blood CD34+ cells. Br J Haematol 2001;113:962-969.
12. Tamaki T, Akatsuka A, Ando K, et al: Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle. J Cell Biol 2002;157:571-577.
13. Zengin E, Chalajour F, Gehling UM, et al: Vascular wall resident progenitor cell: source for postnatal vasculogenesis. Development 2006;133:1543-1551.
14. Vasa M, Fichtlscherer S, Adler K, et al: Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001;103:2885-2890.
15. Michaud SE, Dussault S, Haddad P, et al: Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. Atherosclerosis 2006;187:423-432.
16. Tao J, Wang Y, Yang Z, et al: Circulating endothelial progenitor cell deficiency contributes to impaired arterial elasticity in persons of advancing age. J Hum Hypertens 2006;20:490-495.
17. Hill JM, Zalos G, Halcox JP, et al: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600.
18. Rafii S, Lyden D: Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003;9:702-712.
19. Santarelli JG, Udani V, Yung YC, et al: Incorporation of bone marrow-derived Flk-1-expressing CD34+ cells in the endothelium of tumour vessels in the mouse brain. Neurosurgery 2006;59:374-382.
20. 99mTc- tetrofosmin (TF) perfusion scintigraphy. Cell Transplant 2004;13:429-437.
21. Carmeliet P, Moons L, Luttun A, et al: Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001;7:575-583.
22. Spring H, Schuler T, Arnold B, Hammerling GJ, Ganss R: Chemokines direct endothelial progenitors into tumour neovessels. Proc Natl Acad Sci 2005;102:18111-18116.
23. Naumov GN, Akslen LA, Folkman J: Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Cell Cycle 2006;5:1779-1787.
24. Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, Mittal V: Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 2008;319:195-198.
25. Rigolin GM, Mauro E, Ciccone M, et al: Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia. Eur J Haematol 2007;78:365-373.
26. Shirakawa K, Shibuya M, Heike Y, et al: Tumour-infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancer. Int J Cancer 2002;99:344-351.
27. Sussman LK, Upalakalin JN, Roberts MJ, Kocher O, Benjamin LE: Blood markers for vasculogenesis increase with tumour progression in patients with breast carcinoma. Cancer Biol Ther 2003;2:255-256.
28. Ho JW, Pang RW, Lau C, et al: Significance of circulating endothelial progenitor cells in hepatocellular carcinoma. Hepatology 2006;44:836-843.
29. Dome B, Timar J, Dobos J, et al: Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Res 2006;66:7341-7347.
30. Hilbe W, Dirnhofer S, Oberwasserlechner F, et al: CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J Clin Pathol 2004;57:965-969.
31. Mehra N, Penning M, Maas J, et al: Progenitor marker CD133 mRNA is elevated in peripheral blood of cancer patients with bone metastases. Clin Cancer Res 2006;12:4859-4866.
32. Rabascio C, Muratori E, Mancuso P, et al: Assessing tumour angiogenes: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells. Cancer Res 2004;64:4373-4377.
33. Igreja C, Courinha M, Cachaco AS, et al: Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients. Haematologica 2007;92:469-477.
34. Zhang H, Vakil V, Braunstein M, et al: Circulating endothelial progenitor cells in multiple myeloma: implications and significance. Blood 2005;105:3286-3294.
35. Wierzbowska A, Robak T, Krawczynska A, et al: Circulating endothelial cells in patients with acute myeloid leukemia. Eur J Haematol 2005;75:492-497.
36. Bergers G, Benjamin LE: Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003;3:401-410.
37. Miyata T, Iizasa H, Sai Y, Fujii J, Terasaki T, Nakashima E: Platelet-derived growth factor-BB (PDGF-BB) induces differentiation of bone marrow endothelial progenitor cell-derived cell line TR-BME2 into mural cells, and changes the phenotype. J Cell Physiol 2005;204:948-955.
38. Heissig B, Hattori K, Dias S, et al: Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002;109:625-637.
39. Orimo A, Gupta PB, Sgroi DC, et al: Stromal fibroblasts present in invasive human breast carcinomas promote tumour growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005;121:335-348.
40. Jin H, Aiyer A, Su J, et al: A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. J Clin Invest 2006;116:652-662.
41. Vajkoczy P, Blum S, Lamparter M, et al: Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J Exp Med 2003;197:1755-1765.
42. Davidoff AM, Ng CY, Brown P, et al: Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice. Clin Cancer Res 2001; 7:2870-2879.
43. Garcia-Barros M, Paris F, Cordon-Cardo C, et al: Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003;300:1155-1159.
44. Crosby JR, Kaminski WE, Schatteman G, et al: Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 2000;87:728-730.
45. Machein MR, Renninger S, de Lima-Hahn E, Plate KH: Minor contribution of bone marrow-derived endothelial progenitors to the vascularization of murine gliomas. Brain Pathol 2003;13:582-597.
46. Peters BA, Diaz LA, Polyak K, et al: Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med 2005;11:261-262.
47. Duda DG, Cohen KS, Kozin SV, et al: Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors. Blood 2006;107:2774-2776.
48. Krause DS, Theise ND, Collector MI, et al: Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001;105:369-377.
49. Yamashita J, Itoh H, Hirashima M, et al: Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000;408:92-96.
50. Sainz J, Al Haj Zen A, Caligiuri G, et al: Isolation of 'side population' progenitor cells from healthy arteries of adult mice. Arterioscler Thromb Vasc Biol 2006;26:281-286.
51. Yu DC, Sun XT, Fang S, et al: Validation of endothelial progenitor cells in human umbilical veins and the isolated endothelial cells. Endothelium 2007;14:141-150.
52. Streubel B, Chott A, Huber D, et al: Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas. N Engl J Med 2004;351:250-259.
53. Vassilopoulos G, Wang PR, Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003;422:901-904.
54. Bergsmedh A, Szeles A, Henriksson M, et al: Horizontal transfer of oncogenes by uptake of apoptotic bodies. Proc Natl Acad Sci USA 2001;98:6407-6411.
55. Gunsilius E, Duba HC, Petzer AL, et al: Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet 2000;355:1688-1691.
56. Gothert JR, Gustin SE, van Eekelen JA, et al: Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. Blood 2004;104:1769-1777.
57. Rajantie I, Ilmonen M, Alminaite A, Ozerdem U, Alitalo K, Salven P: Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood 2004;104:2084-2086.
58. +(+) Sca-1+ stem cells do not contribute to vasculogenesis in Lewis lung carcinoma. Neoplasia 2005;7:234-240.
59. Ferrari N, Glod J, Lee J, Kobiler D, Fine HA: Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectors. Gene Ther 2003;10:647-656.
60. Arbab AS, Pandit SD, Anderson SA, et al: Magnetic resonance imaging and confocal microscopy studies of magnetically labeled endothelial progenitor cells trafficking to sites of tumour angiogenesis. Stem Cells 2006;24:671-678.
61. Naik RP, Jin D, Chuang E, Gold EG, et al: Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer. Breast Cancer Res Treat 2008;107:133-138.